GoHealth (GOCO) Projected to Post Quarterly Earnings on Thursday

GoHealth (NASDAQ:GOCO) will likely be announcing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($2.06) per share and revenue of $102.3550 million for the quarter. Interested persons can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:00 AM ET.

GoHealth (NASDAQ:GOCO) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($1.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.60) by $1.37. GoHealth had a negative return on equity of 8.74% and a negative net margin of 3.21%.The firm had revenue of $94.05 million for the quarter, compared to analysts’ expectations of $119.76 million. On average, analysts expect GoHealth to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

GoHealth Stock Down 5.8%

GOCO stock opened at $4.07 on Thursday. The firm has a market cap of $116.44 million, a price-to-earnings ratio of -1.13 and a beta of 1.62. GoHealth has a 1-year low of $4.03 and a 1-year high of $21.00. The firm has a fifty day moving average price of $4.73 and a two-hundred day moving average price of $6.09. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.56 and a quick ratio of 1.56.

Institutional Trading of GoHealth

Several hedge funds have recently added to or reduced their stakes in the business. Corient Private Wealth LLC boosted its position in GoHealth by 7.7% during the 2nd quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock worth $699,000 after acquiring an additional 8,979 shares during the period. Geode Capital Management LLC lifted its holdings in GoHealth by 4.3% in the second quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after purchasing an additional 4,955 shares during the period. Bridgeway Capital Management LLC lifted its holdings in GoHealth by 8.2% in the second quarter. Bridgeway Capital Management LLC now owns 27,066 shares of the company’s stock worth $150,000 after purchasing an additional 2,058 shares during the period. Empowered Funds LLC grew its position in GoHealth by 7.7% in the 1st quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock valued at $307,000 after buying an additional 1,790 shares in the last quarter. Finally, Jane Street Group LLC acquired a new position in GoHealth during the 1st quarter valued at about $177,000. Institutional investors own 24.21% of the company’s stock.

Analysts Set New Price Targets

GOCO has been the topic of several research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of GoHealth in a research note on Tuesday, October 14th. Royal Bank Of Canada lowered their target price on GoHealth from $18.00 to $12.00 and set a “sector perform” rating for the company in a report on Thursday, August 28th. Wall Street Zen downgraded GoHealth from a “hold” rating to a “sell” rating in a report on Friday, July 18th. Finally, Noble Financial restated an “outperform” rating on shares of GoHealth in a research report on Friday, August 8th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $12.00.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.